Skip to main content
Erschienen in: World Journal of Surgery 10/2013

01.10.2013

The Prognostic Relevance of Psammoma Bodies and Ultrasonographic Intratumoral Calcifications in Papillary Thyroid Carcinoma

verfasst von: Jung-Soo Pyo, Guhyun Kang, Dong-Hoon Kim, Chanheun Park, Joo Heon Kim, Jin Hee Sohn

Erschienen in: World Journal of Surgery | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Although psammoma bodies (PB) are found in up to 50 % of papillary thyroid carcinomas (PTC), their clinicopathological significance remains uncertain. The aim of the present study was to determine the clinicopathological significance of PB and the correlation between PB and ultrasonographic intratumoral calcification in PTC.

Methods

The clinicopathological parameters, ultrasonographic calcifications, and the presence of PB were evaluated in 258 surgically resected conventional PTC.

Results

Psammoma bodies were found in 141 of 258 PTC (54.7 %). The presence of PB was significantly correlated with tumor multifocality, extrathyroidal extension, and lymph node metastasis (P = 0.009, P = 0.004, and P < 0.001, respectively), but not with the BRAFV600E mutation. Higher incidences of both intratumoral and extratumoral PB were found in overt PTC (>1 cm) than in papillary microcarcinomas (≤1 cm) (P < 0.001 and P = 0.015, respectively). Extratumoral PB were only identified in 48.9 % of 141 PTC with PB, and PTC with extratumoral PB showed higher incidences of tumor multifocality, extrathyroidal extension, and nodal metastasis compared to PTC with intratumoral PB (P = 0.014, P = 0.005 and P = 0.001, respectively). Ultrasonographic intratumoral calcification corresponded to clusters of intratumoral PB (P < 0.001) and was associated with nodal metastasis (P = 0.026).

Conclusions

The findings of the present study suggest that the presence of PB may be a useful prognostic indicator of aggressive PTC behaviors. In addition, confirmation of ultrasonographic intratumoral calcification would be a useful decision-making criterion when determining the need for preoperative or intraoperative surveillance of nodal metastasis.
Literatur
1.
Zurück zum Zitat Hundahl SA, Fleming ID, Fremgen AM et al (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer 83:2638–2648PubMedCrossRef Hundahl SA, Fleming ID, Fremgen AM et al (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985–1995. Cancer 83:2638–2648PubMedCrossRef
2.
Zurück zum Zitat Leenhardt L, Grosclaude P, Cherie-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14:1056–1060PubMedCrossRef Leenhardt L, Grosclaude P, Cherie-Challine L (2004) Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14:1056–1060PubMedCrossRef
3.
Zurück zum Zitat Davies L, Welch HG (2006) Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg 135:451–457PubMedCrossRef Davies L, Welch HG (2006) Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg 135:451–457PubMedCrossRef
4.
Zurück zum Zitat Sprague BL, Warren Andersen S, Trentham-Dietz A (2008) Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control 19:585–593PubMedCrossRef Sprague BL, Warren Andersen S, Trentham-Dietz A (2008) Thyroid cancer incidence and socioeconomic indicators of health care access. Cancer Causes Control 19:585–593PubMedCrossRef
5.
Zurück zum Zitat Nucera C, Lawler J, Hodin R et al (2010) The BRAFV600E mutation: what is it really orchestrating in thyroid cancer? Oncotarget 1:751–756PubMed Nucera C, Lawler J, Hodin R et al (2010) The BRAFV600E mutation: what is it really orchestrating in thyroid cancer? Oncotarget 1:751–756PubMed
6.
Zurück zum Zitat Bai Y, Zhou G, Nakamura M et al (2009) Survival impact of psammoma body, stromal calcification, and bone formation in papillary thyroid carcinoma. Mod Pathol 22:887–894PubMedCrossRef Bai Y, Zhou G, Nakamura M et al (2009) Survival impact of psammoma body, stromal calcification, and bone formation in papillary thyroid carcinoma. Mod Pathol 22:887–894PubMedCrossRef
7.
Zurück zum Zitat Johannessen JV, Sobrinho-Simoes M (1980) The origin and significance of thyroid psammoma bodies. Lab Invest 43:287–296PubMed Johannessen JV, Sobrinho-Simoes M (1980) The origin and significance of thyroid psammoma bodies. Lab Invest 43:287–296PubMed
8.
Zurück zum Zitat Das DK, Sheikh ZA, George SS et al (2008) Papillary thyroid carcinoma: evidence for intracytoplasmic formation of precursor substance for calcification and its release from well-preserved neoplastic cells. Diagn Cytopathol 36:809–812PubMedCrossRef Das DK, Sheikh ZA, George SS et al (2008) Papillary thyroid carcinoma: evidence for intracytoplasmic formation of precursor substance for calcification and its release from well-preserved neoplastic cells. Diagn Cytopathol 36:809–812PubMedCrossRef
9.
Zurück zum Zitat Triggiani V, Guastamacchia E, Licchelli B et al (2008) Microcalcifications and psammoma bodies in thyroid tumors. Thyroid 18:1017–1018PubMedCrossRef Triggiani V, Guastamacchia E, Licchelli B et al (2008) Microcalcifications and psammoma bodies in thyroid tumors. Thyroid 18:1017–1018PubMedCrossRef
10.
Zurück zum Zitat Das DK (2009) Psammoma body: a product of dystrophic calcification or of a biologically active process that aims at limiting the growth and spread of tumor? Diagn Cytopathol 37:534–541PubMedCrossRef Das DK (2009) Psammoma body: a product of dystrophic calcification or of a biologically active process that aims at limiting the growth and spread of tumor? Diagn Cytopathol 37:534–541PubMedCrossRef
11.
Zurück zum Zitat Koike E, Yamashita H, Noguchi S et al (2001) Effect of combining ultrasonography and ultrasound-guided fine-needle aspiration biopsy findings for the diagnosis of thyroid nodules. Eur J Surg 167:656–661PubMedCrossRef Koike E, Yamashita H, Noguchi S et al (2001) Effect of combining ultrasonography and ultrasound-guided fine-needle aspiration biopsy findings for the diagnosis of thyroid nodules. Eur J Surg 167:656–661PubMedCrossRef
12.
Zurück zum Zitat Seiberling KA, Dutra JC, Grant T et al (2004) Role of intrathyroidal calcifications detected on ultrasound as a marker of malignancy. Laryngoscope 114:1753–1757PubMedCrossRef Seiberling KA, Dutra JC, Grant T et al (2004) Role of intrathyroidal calcifications detected on ultrasound as a marker of malignancy. Laryngoscope 114:1753–1757PubMedCrossRef
13.
Zurück zum Zitat Moon WJ, Jung SL, Lee JH et al (2008) Benign and malignant thyroid nodules: US differentiation—multicenter retrospective study. Radiology 247:762–770PubMedCrossRef Moon WJ, Jung SL, Lee JH et al (2008) Benign and malignant thyroid nodules: US differentiation—multicenter retrospective study. Radiology 247:762–770PubMedCrossRef
14.
Zurück zum Zitat Wang N, Xu Y, Ge C et al (2006) Association of sonographically detected calcification with thyroid carcinoma. Head Neck 28:1077–1083PubMedCrossRef Wang N, Xu Y, Ge C et al (2006) Association of sonographically detected calcification with thyroid carcinoma. Head Neck 28:1077–1083PubMedCrossRef
15.
Zurück zum Zitat Chen G, Zhu XQ, Zou X et al (2009) Retrospective analysis of thyroid nodules by clinical and pathological characteristics, and ultrasonographically detected calcification correlated to thyroid carcinoma in South China. Eur Surg Res 42:137–142PubMedCrossRef Chen G, Zhu XQ, Zou X et al (2009) Retrospective analysis of thyroid nodules by clinical and pathological characteristics, and ultrasonographically detected calcification correlated to thyroid carcinoma in South China. Eur Surg Res 42:137–142PubMedCrossRef
16.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC et al (2009) Thyroid. The AJCC cancer staging manual, 7th edn. Springer, New York, pp 87–100 Edge SB, Byrd DR, Compton CC et al (2009) Thyroid. The AJCC cancer staging manual, 7th edn. Springer, New York, pp 87–100
17.
Zurück zum Zitat Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214PubMedCrossRef Cooper DS, Doherty GM, Haugen BR et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214PubMedCrossRef
18.
Zurück zum Zitat Park YJ, Kim YA, Lee YJ et al (2010) Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings. Head Neck 32:38–45PubMedCrossRef Park YJ, Kim YA, Lee YJ et al (2010) Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings. Head Neck 32:38–45PubMedCrossRef
19.
Zurück zum Zitat Khoo ML, Asa SL, Witterick IJ et al (2002) Thyroid calcification and its association with thyroid carcinoma. Head Neck 24:651–655PubMedCrossRef Khoo ML, Asa SL, Witterick IJ et al (2002) Thyroid calcification and its association with thyroid carcinoma. Head Neck 24:651–655PubMedCrossRef
20.
Zurück zum Zitat Hayashi N, Tamaki N, Yamamoto K et al (1986) Real-time ultrasonography of thyroid nodules. Acta Radiol Diagn (Stockh) 27:403–408 Hayashi N, Tamaki N, Yamamoto K et al (1986) Real-time ultrasonography of thyroid nodules. Acta Radiol Diagn (Stockh) 27:403–408
21.
Zurück zum Zitat Watters DA, Ahuja AT, Evans RM et al (1992) Role of ultrasound in the management of thyroid nodules. Am J Surg 164:654–657PubMedCrossRef Watters DA, Ahuja AT, Evans RM et al (1992) Role of ultrasound in the management of thyroid nodules. Am J Surg 164:654–657PubMedCrossRef
22.
23.
Zurück zum Zitat Sugitani I, Fujimoto Y, Yamada K et al (2008) Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography. World J Surg 32:2494–2502. doi:10.1007/s00268-008-9711-9 PubMedCrossRef Sugitani I, Fujimoto Y, Yamada K et al (2008) Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography. World J Surg 32:2494–2502. doi:10.​1007/​s00268-008-9711-9 PubMedCrossRef
24.
Zurück zum Zitat Roh JL, Park JY, Kim JM et al (2009) Use of preoperative ultrasonography as guidance for neck dissection in patients with papillary thyroid carcinoma. J Surg Oncol 99:28–31PubMedCrossRef Roh JL, Park JY, Kim JM et al (2009) Use of preoperative ultrasonography as guidance for neck dissection in patients with papillary thyroid carcinoma. J Surg Oncol 99:28–31PubMedCrossRef
26.
Zurück zum Zitat Lee HJ, Choi J, Hwang TS et al (2010) Detection of BRAF mutations in thyroid nodules by allele-specific PCR using a dual priming oligonucleotide system. Am J Clin Pathol 133:802–808PubMedCrossRef Lee HJ, Choi J, Hwang TS et al (2010) Detection of BRAF mutations in thyroid nodules by allele-specific PCR using a dual priming oligonucleotide system. Am J Clin Pathol 133:802–808PubMedCrossRef
27.
Zurück zum Zitat Kwak JY, Kim EK, Kim JK et al (2010) Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAFV600E mutation-prevalent area. Head Neck 32:490–498PubMed Kwak JY, Kim EK, Kim JK et al (2010) Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAFV600E mutation-prevalent area. Head Neck 32:490–498PubMed
Metadaten
Titel
The Prognostic Relevance of Psammoma Bodies and Ultrasonographic Intratumoral Calcifications in Papillary Thyroid Carcinoma
verfasst von
Jung-Soo Pyo
Guhyun Kang
Dong-Hoon Kim
Chanheun Park
Joo Heon Kim
Jin Hee Sohn
Publikationsdatum
01.10.2013
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 10/2013
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2107-5

Weitere Artikel der Ausgabe 10/2013

World Journal of Surgery 10/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.